Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-017221
Filing Date
2026-05-15
Accepted
2026-05-15 08:05:55
Documents
60
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20260331_10q.htm   iXBRL 10-Q 593135
2 EXHIBIT 31.1 ex_959746.htm EX-31.1 12521
3 EXHIBIT 31.2 ex_959747.htm EX-31.2 11196
4 EXHIBIT 32.1 ex_959748.htm EX-32.1 4289
5 EXHIBIT 32.2 ex_959749.htm EX-32.2 4305
  Complete submission text file 0001437749-26-017221.txt   3529677

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20260331.xsd EX-101.SCH 39738
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20260331_def.xml EX-101.DEF 230238
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20260331_lab.xml EX-101.LAB 203987
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20260331_pre.xml EX-101.PRE 259537
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20260331_cal.xml EX-101.CAL 24982
64 EXTRACTED XBRL INSTANCE DOCUMENT bcda20260331_10q_htm.xml XML 447143
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 26982413
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)